NCT04138849View on ClinicalTrials.gov

Evaluate Safety, Pharmacokinetics and Pharmacodynamics of BBT-877 in Healthy Japanese Male

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

October 25, 2019

Study Completion Date

October 25, 2019

Conditions
Healthy Participants
Interventions
DRUG

BBT-877 single dose

Oral capsule, single dose.

DRUG

Placebo single dose

Oral capsule, single dose.

Trial Locations (1)

90630

WCCT, Cypress

Sponsors

Collaborators (1)

KCRN Research, LLC
All Listed Sponsors
collaborator

KCRN Research, LLC

INDUSTRY

lead

Bridge Biotherapeutics, Inc.

INDUSTRY

NCT04138849 - Evaluate Safety, Pharmacokinetics and Pharmacodynamics of BBT-877 in Healthy Japanese Male | Biotech Hunter | Biotech Hunter